Abstract
Objective So-called “Visual Restitution Therapies” (VRT) claim to ameliorate visual field defects of neurological patients by repeated visual light stimulation, leading to training-related neuroplasticity and resulting in reconnection of lesioned neurons in early cortical areas. Because existing systems are stationary, uncomfortable and unreliable, we developed a training instrument based on virtual reality goggles. The goal of the “Salzburg Visual Field Trainer” (SVFT) is twofold: (1) The device facilitates the clinical evaluation of established neuropsychological rehabilitation approaches, such as VRT. (2) The device enables patients to independently perform VRT based (or other) neuropsychological training methodologies flexibly, comfortably and reliably.
Methods and Analysis The SVFT was developed on the principles of VRT. Individual configuration of the SVFT is based on perimetric data of the respective patient’s visual field. To validate the utmost important procedure in neuropsychological rehabilitation methodologies - that is displaying stimuli precisely in desired locations in the user’s visual field - two steps were conducted in this proof-of-concept study: First, we assessed the individual “blind spots” location and extent of 40 healthy, normal sighted participants. This was done with the help of our recently developed and validated perimetric methodology “Eye Tracking Based Visual Field Analysis” (EFA). Second, depending on the individual characteristics of every participant’s blind spots, we displayed - with the help of the SVFT - 15 stimuli in the respective locations of every participants’ blind spots and 85 stimuli in the surrounding, fully intact visual area. The ratio between visible and non-visible stimuli, which reflects in the documented behavioral response (clicks on a remote control) of the 40 participants, provides insight into the accuracy of the SVFT to display training stimuli in areas desired by the investigator. As the blind spot is a naturally occurring, absolute scotoma in human vision, we utilized this blind area as an objective criterion and a “simulated” visual field defect to evaluate the (technical) methodology of SVFT.
Results Outcomes indicate that the SVFT and its methodology is highly accurate in displaying training stimuli in desired areas of the user’s visual field with an accuracy of 99.0%. Data analysis further shows a sensitivity of .980, specificity of .992, positive predictive value of .955, negative predictive value of .996, hit rate of .990, random hit rate of .742 and RATZ-Index of .976. This translates to 14.7% correct non-reactions, 0.7% false non-reactions, 0.3% false reactions and 84.3% correct reactions to displayed test stimuli during the evaluation study with the SVFT. Reports from participants further indicate that the SVFT is comfortable to wear and intuitive to use.
Conclusions The SVFT can help to investigate the true effects of VRT based methodologies (or other neuropsychological approaches) and the underlying mechanisms of training-related neuroplasticity in early regions of the visual cortex in neurological patients suffering from visual field defects.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The following study is based on the funded project "Advanced Perimetry for the Evaluation of Neuroplasticity in the Visual Cortex" by the Austrian Science Fund (FWF) (Reference No. P31299)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The following study was reviewed and approved by the ethics commission of the University of Salzburg (Reference No. 39/2018)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The following study was reviewed and approved by the ethics commission of the University of Salzburg (Reference No. 39/2018)
The following study is based on the funded project “Advanced Perimetry for the Evaluation of Neuroplasticity in the Visual Cortex” by the Austrian Science Fund (FWF) (Reference No. P31299)
All authors declare that they have no conflict of interest and approve the manuscript
Data Availability
Data is available from the corresponding author upon reasonable request
